- Published at
- by manilatimes.net
neutral
neutral
News for Destiny Pharma plc (DEST.L)
- Published at
- by globenewswire.com
mixedmixedCorrection - Annual Financial Report
THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95 07 AUGUST 2024CORRECTION - FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024 The Board notes that the...- Published at
- by globenewswire.com
mixedmixedAnnual Financial Report
THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95 31 JULY 2024FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024 Thames Ventures VCT 2 plc, managed by...- Published at
- by marketscreener.com
positivepositiveDestiny Pharma presents "exciting" data for ringworm drug
Destiny Pharma PLC - biotechnology company, focused on developing and commercialising medicines for life-threatening infections - Announces new data on one of its XF Drug Platform compounds, XF-70,...- Published at
- by marketscreener.com
positivepositiveDestiny Pharma : Result of 2024 Annual General Meeting
DESTINY PHARMA PLC Results of the Annual General Meeting held on 12 June 2024 ...- Published at
- by globenewswire.com
mixedmixedAntibiotic Resistance Market Projected to Hit US$ 17.8 Billion by 2033 with a CAGR of 5.3% | Persistence Market Research
Explore the Antibiotic Resistance Market: Discover the latest trends, key players, and innovative solutions tackling the global healthcare challenge of...- Published at
- by globenewswire.com
mixedmixedHalf Yearly Results
Thames Ventures VCT 2 plcLEI: 21380035MV1VRYEXPR95Half Yearly Results21 December 2023 Financial Highlights Unaudited30 September 2023pence Unaudited30...- Published at
- by marketscreener.com
mixedmixedAIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data -October 17, 2023 at 05:20 am EDT
The following stocks are the leading risers and fallers on AIM in London on Tuesday. ---------- AIM - WINNERS ---------- Destiny Pharma PLC, up 19% at 56.99 pence, 12-month range 25p-61.85p. The...- Published at
- by globenewswire.com
mixedmixedLive Biotherapeutic Product (LBP) Market is Riding the Wave of Growth and Expected to Grow at a CAGR of 21.2 % to 2031 | Reveals Latest InsightAce Study
Companies covered in this report are Seres Therapeutics, Inc., Microbiotica, Enterome, Destiny Pharma plc, Taisho Pharmaceutical Holdings, AOBiome...- Published at
- by globenewswire.com
mixedmixed- Published at
- by marketscreener.com
positivepositiveDestiny Pharma picks interim CEO as Clark makes quick exit
Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately to... | May 25, 2023- Published at
- by marketscreener.com
mixedmixedMacfarlane buys A&G Holdings for GBP3.6 million
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- NetScientific PLC - life sciences and sustainability... | May 2, 2023- Published at
- by marketscreener.com
mixedmixedTRADING UPDATES: Appreciate gets court date; Corcel completes sale
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Appreciate Group PLC - Merseyside, England-based... | January 25, 2023- Published at
- by prnewswire.com
mixedmixedGlobal Antibiotic Resistance Market Research Report 2023: The Key Large Market Opportunities in AMR & Therapeutic Technology Developments
/PRNewswire/ -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...- Published at
- by marketscreener.com
mixedmixedHalf-year report
Thames Ventures VCT 2 plcLEI: 21380035MV1VRYEXPR95Half Yearly Results22 December 2022 Financial Highlights Unaudited30 September 2022penceAudited31March... | December 22, 2022- Published at
- by globenewswire.com
mixedmixedHalf-year report
Thames Ventures VCT 2 plcLEI: 21380035MV1VRYEXPR95Half Yearly Results22 December 2022 Financial Highlights Unaudited30 September 2022penceAudited31March...- Published at
- by prnewswire.com
mixedmixedGlobal Microbiome Therapeutics Market Report 2022: Featuring 4D Pharma, Enterome, Finch Therapeutics, Vedanta Bioscience & More
/PRNewswire/ -- The "Global Microbiome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (FMT...- Published at
- by globenewswire.com
mixedmixed- Published at
- by prnewswire.com
mixedmixedLive Biotherapeutic Product (LBP) Market worth $ 2.60 billion by 2030 - Exclusive Report by InsightAce Analytic
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Live Biotherapeutic Product (LBP) Market...- Published at
- by prnewswire.com
mixedmixed